G&E Herbal Biotechnology vs PEC: monthly revenue

Monthly revenue and year-on-year change for G&E Herbal Biotechnology (4911) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ G&E Herbal Biotechnology ━ PEC

0%+108%-61%25/1026/0126/0426/0726/10

Monthly revenue history

MonthG&E Herbal BiotechnologyYoYPECYoY
Oct 2026NT$11.6 million-50.7%NT$2.84 billion+102.0%
Sep 2026NT$11.4 million-56.0%NT$2.64 billion+100.0%
Aug 2026NT$11.6 million-55.3%NT$2.62 billion+105.4%
Jul 2026NT$11.3 million-59.5%NT$2.51 billion+92.6%
Jun 2026NT$11.6 million-57.6%NT$2.33 billion+94.9%
May 2026NT$11.6 million-56.9%NT$2.46 billion+108.5%
Apr 2026NT$11.3 million-56.4%NT$2.06 billion+68.3%
Mar 2026NT$10.6 million-59.8%NT$1.94 billion+64.4%
Feb 2026NT$10.8 million-58.7%NT$1.6 billion+56.7%
Jan 2026NT$10.7 million-60.9%NT$1.58 billion+49.8%
Dec 2025NT$22.8 million-6.5%NT$1.92 billion+69.9%
Nov 2025NT$22.8 million-4.3%NT$1.55 billion+53.0%
Oct 2025NT$23.6 million-0.2%NT$1.4 billion+53.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16